• Skip to main content
  • Skip to primary sidebar

Experienced Indiana Law Firm | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad, LLP | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad is rated highly on Google Reviews by clients.
Toll Free866.446.7478Toll Free317.636.6481
Make a Payment free consult
  • English
  • Español

Search

  • About Us
  • Attorneys
  • Services
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    • Español

Home » FDA Issues Safety Notice Increased Risk of Bladder Cancer Linked to Actos

FDA Issues Safety Notice Increased Risk of Bladder Cancer Linked to Actos

Actos Bladder Cancer Injury Attorneys in Indiana

The FDA recently issued an updated safety notice related to an increased risk for bladder cancer for patients taking Actos and other pioglitazone-containing medicines including Actoplus Met, Actoplus Met XR, Duetact, and Oseni. The initial safety notice was based off interim results from a 10-year study to assess the risks for bladder cancer associated with use of Actos and similar drugs. This new safety notice includes an approved label update about an increased risk for bladder cancer after additional studies were reviewed.

The new safety notice warns patients to contact their healthcare provider if they experience blood or a red color in the urine, new or worsening urge to urinate, or pain when urinating as these may all be symptoms of bladder cancer. It also warns health care professionals to not prescribe Actos and other pioglitazone-containing drugs to patients who currently have bladder cancer or a history of bladder cancer.

If you or someone you know has been prescribed Actos, Actoplus Met, Actoplus Met XR, Duetact, or Oseni and has been diagnosed with bladder cancer, contact us. Our product liability attorneys have litigated thousands of cases against pharmaceutical manufacturers and can provide you with a free case evaluation and advise you of your legal rights and options.

Primary Sidebar

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.

CohenMalad, LLP

One Indiana Square Suite 1400
Indianapolis, Indiana 46204
317.636.6481
Toll Free: 866.446.7478
  • twitter logo

Copyright © 2025 CohenMalad, LLP
Disclaimer Privacy Policy

  • About Us
  • Attorneys
  • Services
    ▼
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    ▼
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    ▼
    • Español
Cookies and other technology are used on this website to tailor your user experience and evaluate our marketing strategy. By clicking any link on this site you agree to our privacy policy.
En este sitio web utilizamos cookies y otras tecnologías para personalizar su experiencia de usuario y evaluar nuestra estrategia de marketing. Al hacer clic en cualquier enlace de esta plataforma, usted acepta nuestra política de privacidad.
Agree